JNJ 4Q16 sales increased 7.6% YoY—if you exclude several things: http://finance.yahoo.com/news/johnson-johnson-reports-2016-fourth-114000089.html As a reminder, there were additional shipping days in the fourth quarter of 2015 that negatively impacted the current quarter by 480 basis points. Excluding the net impact of acquisitions, divestitures, hepatitis C, Venezuela, and the additional shipping days in 2015, on an operational basis [i.e. excluding currency swings], worldwide sales increased 7.6%... Without the above exclusions, 4Q16 sales increased 1.7%. 4Q16 Imbruvica sales increased 47% YoY to $346M. CC slides: http://www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=924927&filekey=15D6B809-FBF4-4096-AFE2-1D1DD7BAF825&filename=JNJ_Earnings_Presentation_4Q2016.pdf Sales of leading products: http://www.investor.jnj.com/common/download/download.cfm?companyid=JNJ&fileid=924677&filekey=ACE5F259-F6F1-4BB2-9D09-1075DD7F6E9C&filename=Sales_of_Key_Products_Franchises_4Q2016.pdf JNJ is trading -2% as I’m typing.